Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 641

1.

[Revised version of the 4th edition of the WHO classification of malignant lymphomas : What is new?]

Ott G, Klapper W, Feller AC, Hansmann ML, Möller P, Stein H, Rosenwald A, Fend F.

Pathologe. 2018 Jul 17. doi: 10.1007/s00292-018-0456-4. [Epub ahead of print] Review. German.

PMID:
30019203
2.

The Impact of Early Corticosteroid Pretreatment Before Initiation of Chemotherapy in Patients With Primary Central Nervous System Lymphoma.

Gessler F, Bernstock JD, Behmanesh B, Brunnberg U, Harter P, Ye D, Friedman GK, Hansmann ML, Wagner M, Seifert V, Weise L, Marquardt G.

Neurosurgery. 2018 Jul 17. doi: 10.1093/neuros/nyy272. [Epub ahead of print]

PMID:
30016483
3.

LRPAP1 is a frequent proliferation-inducing antigen of BCRs of mantle cell lymphomas and can be used for specific therapeutic targeting.

Thurner L, Hartmann S, Fadle N, Kemele M, Bock T, Bewarder M, Regitz E, Neumann F, Nimmesgern A, von Müller L, Pott C, Kim YJ, Bohle RM, Wasik M, Schuster SJ, Hansmann ML, Preuss KD, Pfreundschuh M.

Leukemia. 2018 Jun 28. doi: 10.1038/s41375-018-0182-1. [Epub ahead of print]

PMID:
29955130
4.

Human CD30+ B cells represent a unique subset related to Hodgkin lymphoma cells.

Weniger MA, Tiacci E, Schneider S, Arnolds J, Rüschenbaum S, Duppach J, Seifert M, Döring C, Hansmann ML, Küppers R.

J Clin Invest. 2018 Jun 11. pii: 95993. doi: 10.1172/JCI95993. [Epub ahead of print]

5.

Synthesis of Azaphosphinines by Directed Inverse Electron Demand Hetero-Diels-Alder Reactions with Na(OCP).

Hansmann MM.

Chemistry. 2018 May 17. doi: 10.1002/chem.201802173. [Epub ahead of print]

PMID:
29770987
6.
7.

Microsatellite Instability Occurs Rarely in Patients with Cholangiocarcinoma: A Retrospective Study from a German Tertiary Care Hospital.

Winkelmann R, Schneider M, Hartmann S, Schnitzbauer AA, Zeuzem S, Peveling-Oberhag J, Hansmann ML, Walter D.

Int J Mol Sci. 2018 May 9;19(5). pii: E1421. doi: 10.3390/ijms19051421.

8.

Round-robin test for the cell-of-origin classification of diffuse large B-cell lymphoma-a feasibility study using full slide staining.

Reinke S, Richter J, Fend F, Feller A, Hansmann ML, Hüttl K, Oschlies I, Ott G, Möller P, Rosenwald A, Stein H, Altenbuchinger M, Spang R, Klapper W.

Virchows Arch. 2018 May 5. doi: 10.1007/s00428-018-2367-4. [Epub ahead of print]

PMID:
29730836
9.

Intercepting a Transient Phosphino-Arsinidene.

Hinz A, Hansmann MM, Bertrand G, Goicoechea JM.

Chemistry. 2018 Jul 5;24(38):9514-9519. doi: 10.1002/chem.201802175. Epub 2018 Jun 5.

PMID:
29723432
10.

Sequencing of intraductal biopsies is feasible and potentially impacts clinical management of patients with indeterminate biliary stricture and cholangiocarcinoma.

Bankov K, Döring C, Schneider M, Hartmann S, Winkelmann R, Albert JG, Bechstein WO, Zeuzem S, Hansmann ML, Peveling-Oberhag J, Walter D.

Clin Transl Gastroenterol. 2018 Apr 30;9(4):151. doi: 10.1038/s41424-018-0015-6.

11.

[Aggressive B‑cell lymphomas : Recommendations from the German Panel of Reference Pathologists in the Competence Network on Malignant Lymphomas on diagnostic procedures according to the current WHO classification, update 2017].

Klapper W, Fend F, Feller A, Hansmann ML, Möller P, Stein H, Rosenwald A, Ott G.

Pathologe. 2018 Apr 17. doi: 10.1007/s00292-018-0440-z. [Epub ahead of print] Review. German.

PMID:
29666909
12.

Ectopic expression of transcription factor BATF3 induces B-cell lymphomas in a murine B-cell transplantation model.

Weiser C, Petkova MV, Rengstl B, Döring C, von Laer D, Hartmann S, Küppers R, Hansmann ML, Newrzela S.

Oncotarget. 2018 Mar 23;9(22):15942-15951. doi: 10.18632/oncotarget.24639. eCollection 2018 Mar 23.

13.

CD30-targeted oncolytic viruses as novel therapeutic approach against classical Hodgkin lymphoma.

Hanauer JDS, Rengstl B, Kleinlützum D, Reul J, Pfeiffer A, Friedel T, Schneider IC, Newrzela S, Hansmann ML, Buchholz CJ, Muik A.

Oncotarget. 2018 Jan 12;9(16):12971-12981. doi: 10.18632/oncotarget.24191. eCollection 2018 Feb 27.

14.

Genetic heterogeneity of primary lesion and metastasis in small intestine neuroendocrine tumors.

Walter D, Harter PN, Battke F, Winkelmann R, Schneider M, Holzer K, Koch C, Bojunga J, Zeuzem S, Hansmann ML, Peveling-Oberhag J, Waidmann O.

Sci Rep. 2018 Feb 28;8(1):3811. doi: 10.1038/s41598-018-22115-0.

15.

Modular Approach to Kekulé Diradicaloids Derived from Cyclic (Alkyl)(amino)carbenes.

Hansmann MM, Melaimi M, Munz D, Bertrand G.

J Am Chem Soc. 2018 Feb 21;140(7):2546-2554. doi: 10.1021/jacs.7b11183. Epub 2018 Feb 9.

PMID:
29382199
16.

Multicenter validation of cancer gene panel-based next-generation sequencing for translational research and molecular diagnostics.

Hirsch B, Endris V, Lassmann S, Weichert W, Pfarr N, Schirmacher P, Kovaleva V, Werner M, Bonzheim I, Fend F, Sperveslage J, Kaulich K, Zacher A, Reifenberger G, Köhrer K, Stepanow S, Lerke S, Mayr T, Aust DE, Baretton G, Weidner S, Jung A, Kirchner T, Hansmann ML, Burbat L, von der Wall E, Dietel M, Hummel M.

Virchows Arch. 2018 Apr;472(4):557-565. doi: 10.1007/s00428-017-2288-7. Epub 2018 Jan 27.

17.

Organic Mixed Valence Compounds Derived from Cyclic (Alkyl)(amino)carbenes.

Hansmann MM, Melaimi M, Bertrand G.

J Am Chem Soc. 2018 Feb 14;140(6):2206-2213. doi: 10.1021/jacs.7b11184. Epub 2018 Feb 1.

PMID:
29342351
18.

Clinical relevance and concordance of HER2 status in local and central testing-an analysis of 1581 HER2-positive breast carcinomas over 12 years.

Pfitzner BM, Lederer B, Lindner J, Solbach C, Engels K, Rezai M, Dohnal K, Tesch H, Hansmann ML, Salat C, Beer M, Schneeweiss A, Sinn P, Bankfalvi A, Darb-Esfahani S, von Minckwitz G, Sinn BV, Kronenwett R, Weber K, Denkert C, Loibl S.

Mod Pathol. 2018 Apr;31(4):607-615. doi: 10.1038/modpathol.2017.171. Epub 2017 Dec 22.

PMID:
29271415
19.

Complex Immune Evasion Strategies in Classical Hodgkin Lymphoma.

Wein F, Weniger MA, Höing B, Arnolds J, Hüttmann A, Hansmann ML, Hartmann S, Küppers R.

Cancer Immunol Res. 2017 Dec;5(12):1122-1132. doi: 10.1158/2326-6066.CIR-17-0325. Epub 2017 Oct 25.

PMID:
29070649
20.

Crystalline Monomeric Allenyl/Propargyl Radical.

Hansmann MM, Melaimi M, Bertrand G.

J Am Chem Soc. 2017 Nov 8;139(44):15620-15623. doi: 10.1021/jacs.7b09622. Epub 2017 Oct 25.

PMID:
29046060
21.

Femtosecond Laser-Assisted Capsulotomy: Histological Comparison of Four Different Laser Platforms.

Hengerer FH, Mittelbronn M, Hansmann ML, Auffarth GU, Conrad-Hengerer I.

J Refract Surg. 2017 Oct 1;33(10):670-675. doi: 10.3928/1081597X-20170718-01.

PMID:
28991334
22.

Advanced patient age at diagnosis of diffuse large B-cell lymphoma is associated with molecular characteristics including ABC-subtype and high expression of MYC.

Paul U, Richter J, Stuhlmann-Laiesz C, Kreuz M, Nagel I, Horn H, Staiger AM, Aukema SM, Hummel M, Ott G, Spang R, Rosenwald A, Feller AC, Cogliatti S, Stein H, Hansmann ML, Moller P, Szczepanowski M, Burkhardt B, Pfreundschuh M, Schmitz N, Loeffler M, Trümper L, Siebert R, Klapper W.

Leuk Lymphoma. 2018 May;59(5):1213-1221. doi: 10.1080/10428194.2017.1365851. Epub 2017 Aug 25.

PMID:
28838257
23.

An oncogenic axis of STAT-mediated BATF3 upregulation causing MYC activity in classical Hodgkin lymphoma and anaplastic large cell lymphoma.

Lollies A, Hartmann S, Schneider M, Bracht T, Weiß AL, Arnolds J, Klein-Hitpass L, Sitek B, Hansmann ML, Küppers R, Weniger MA.

Leukemia. 2018 Jan;32(1):92-101. doi: 10.1038/leu.2017.203. Epub 2017 Jun 29.

PMID:
28659618
24.

TP53 mutation and survival in aggressive B cell lymphoma.

Zenz T, Kreuz M, Fuge M, Klapper W, Horn H, Staiger AM, Winter D, Helfrich H, Huellein J, Hansmann ML, Stein H, Feller A, Möller P, Schmitz N, Trümper L, Loeffler M, Siebert R, Rosenwald A, Ott G, Pfreundschuh M, Stilgenbauer S; German High-Grade Non-Hodgkin Lymphoma Study Group (DSHNHL).

Int J Cancer. 2017 Oct 1;141(7):1381-1388. doi: 10.1002/ijc.30838. Epub 2017 Jun 26.

PMID:
28614910
25.

Corrigendum: SAMHD1 is a biomarker for cytarabine response and a therapeutic target in acute myeloid leukemia.

Schneider C, Oellerich T, Baldauf HM, Schwarz SM, Thomas D, Flick R, Bohnenberger H, Kaderali L, Stegmann L, Cremer A, Martin M, Lohmeyer J, Michaelis M, Hornung V, Schliemann C, Berdel WE, Hartmann W, Wardelmann E, Comoglio F, Hansmann ML, Yakunin AF, Geisslinger G, Ströbel P, Ferreirós N, Serve H, Keppler OT, Cinatl J Jr.

Nat Med. 2017 Jun 6;23(6):788. doi: 10.1038/nm0617-788a. No abstract available.

PMID:
28586337
26.

(Phosphanyl)phosphaketenes as building blocks for novel phosphorus heterocycles.

Hansmann MM, Ruiz DA, Liu LL, Jazzar R, Bertrand G.

Chem Sci. 2017 May 1;8(5):3720-3725. doi: 10.1039/c7sc00300e. Epub 2017 Mar 8.

27.

Thioredoxin-1, chemokine (C-X-C motif) ligand-9 and interferon-γ expression in the neoplastic cells and macrophages of Hodgkin lymphoma: clinicopathologic correlations and potential prognostic implications.

P Vassilakopoulos T, Levidou G, Milionis V, Hartmann S, Lakiotaki E, Sepsa A, Thymara I, Ntailiani P, Spanou K, K Angelopoulou M, P Siakantaris M, Moschogiannis M, A Pangalis G, Panayiotidis P, Konstantopoulos K, Patsouris E, Hansmann ML, Korkolopoulou P.

Leuk Lymphoma. 2017 Sep;58(9):1-13. doi: 10.1080/10428194.2017.1289520. Epub 2017 Jun 2.

PMID:
28571489
28.

Bicyclic (Alkyl)(amino)carbenes (BICAACs): Stable Carbenes More Ambiphilic than CAACs.

Tomás-Mendivil E, Hansmann MM, Weinstein CM, Jazzar R, Melaimi M, Bertrand G.

J Am Chem Soc. 2017 Jun 14;139(23):7753-7756. doi: 10.1021/jacs.7b04640. Epub 2017 Jun 1.

PMID:
28541687
29.

Clinical Impact of the Cell-of-Origin Classification and the MYC/ BCL2 Dual Expresser Status in Diffuse Large B-Cell Lymphoma Treated Within Prospective Clinical Trials of the German High-Grade Non-Hodgkin's Lymphoma Study Group.

Staiger AM, Ziepert M, Horn H, Scott DW, Barth TFE, Bernd HW, Feller AC, Klapper W, Szczepanowski M, Hummel M, Stein H, Lenze D, Hansmann ML, Hartmann S, Möller P, Cogliatti S, Lenz G, Trümper L, Löffler M, Schmitz N, Pfreundschuh M, Rosenwald A, Ott G; German High-Grade Lymphoma Study Group.

J Clin Oncol. 2017 Aug 1;35(22):2515-2526. doi: 10.1200/JCO.2016.70.3660. Epub 2017 May 19.

PMID:
28525305
30.

Small and big Hodgkin-Reed-Sternberg cells of Hodgkin lymphoma cell lines L-428 and L-1236 lack consistent differences in gene expression profiles and are capable to reconstitute each other.

Rengstl B, Kim S, Döring C, Weiser C, Bein J, Bankov K, Herling M, Newrzela S, Hansmann ML, Hartmann S.

PLoS One. 2017 May 15;12(5):e0177378. doi: 10.1371/journal.pone.0177378. eCollection 2017.

31.

PD-L1 expression in extrahepatic cholangiocarcinoma.

Walter D, Herrmann E, Schnitzbauer AA, Zeuzem S, Hansmann ML, Peveling-Oberhag J, Hartmann S.

Histopathology. 2017 Sep;71(3):383-392. doi: 10.1111/his.13238. Epub 2017 Jun 23.

PMID:
28419539
32.

TET2 mutations in B cells of patients affected by angioimmunoblastic T-cell lymphoma.

Schwartz FH, Cai Q, Fellmann E, Hartmann S, Mäyränpää MI, Karjalainen-Lindsberg ML, Sundström C, Scholtysik R, Hansmann ML, Küppers R.

J Pathol. 2017 Jun;242(2):129-133. doi: 10.1002/path.4898. Epub 2017 May 3.

PMID:
28337768
33.

Eosinophilic cholangitis is a potentially underdiagnosed etiology in indeterminate biliary stricture.

Walter D, Hartmann S, Herrmann E, Peveling-Oberhag J, Bechstein WO, Zeuzem S, Hansmann ML, Friedrich-Rust M, Albert JG.

World J Gastroenterol. 2017 Feb 14;23(6):1044-1050. doi: 10.3748/wjg.v23.i6.1044.

34.

Direct Access to π-Extended Phosphindolium Salts by Simple Proton-Induced Cyclization of (o-Alkynylphenyl)phosphanes.

Arndt S, Hansmann MM, Rominger F, Rudolph M, Hashmi ASK.

Chemistry. 2017 Apr 24;23(23):5429-5433. doi: 10.1002/chem.201700889. Epub 2017 Apr 3.

PMID:
28244159
35.

Gold-Catalyzed Formal Cyclisation/Dimerization of Thiophene-Tethered Diynes.

Tšupova S, Hansmann MM, Rudolph M, Rominger F, Hashmi ASK.

Chemistry. 2017 Apr 27;23(24):5716-5721. doi: 10.1002/chem.201700061. Epub 2017 Mar 20.

PMID:
28182840
36.

Intratumoral heterogeneity of intrahepatic cholangiocarcinoma.

Walter D, Döring C, Feldhahn M, Battke F, Hartmann S, Winkelmann R, Schneider M, Bankov K, Schnitzbauer A, Zeuzem S, Hansmann ML, Peveling-Oberhag J.

Oncotarget. 2017 Feb 28;8(9):14957-14968. doi: 10.18632/oncotarget.14844.

37.

Identification of novel follicular dendritic cell sarcoma markers, FDCSP and SRGN, by whole transcriptome sequencing.

Lorenzi L, Döring C, Rausch T, Benes V, Lonardi S, Bugatti M, Campo E, Cabeçadas J, Simonitsch-Klupp I, Borges A, Mehta J, Agostinelli C, Pileri SA, Facchetti F, Hansmann ML, Hartmann S.

Oncotarget. 2017 Mar 7;8(10):16463-16472. doi: 10.18632/oncotarget.14864.

38.

Distinctive Histogenesis and Immunological Microenvironment Based on Transcriptional Profiles of Follicular Dendritic Cell Sarcomas.

Laginestra MA, Tripodo C, Agostinelli C, Motta G, Hartmann S, Döring C, Rossi M, Melle F, Sapienza MR, Tabanelli V, Pileri A, Fuligni F, Gazzola A, Mannu C, Sagramoso CA, Lonardi S, Lorenzi L, Bacci F, Sabattini E, Borges A, Simonitsch-Klupp I, Cabecadas J, Campo E, Rosai J, Hansmann ML, Facchetti F, Pileri SA.

Mol Cancer Res. 2017 May;15(5):541-552. doi: 10.1158/1541-7786.MCR-16-0301. Epub 2017 Jan 27.

39.

Intramolecular anti-Phosphinoauration of Alkynes: An FLP-Motivated Approach to Stable Aurated Phosphindolium Complexes.

Arndt S, Hansmann MM, Motloch P, Rudolph M, Rominger F, Hashmi AS.

Chemistry. 2017 Feb 21;23(11):2542-2547. doi: 10.1002/chem.201605914. Epub 2017 Feb 3.

PMID:
28002628
40.

[Update on nodular lymphocyte predominant Hodgkin's lymphoma and related lesions].

Hartmann S, Hansmann ML.

Pathologe. 2017 Feb;38(1):3-10. doi: 10.1007/s00292-016-0257-6. Review. German.

PMID:
27999937
41.

SAMHD1 is a biomarker for cytarabine response and a therapeutic target in acute myeloid leukemia.

Schneider C, Oellerich T, Baldauf HM, Schwarz SM, Thomas D, Flick R, Bohnenberger H, Kaderali L, Stegmann L, Cremer A, Martin M, Lohmeyer J, Michaelis M, Hornung V, Schliemann C, Berdel WE, Hartmann W, Wardelmann E, Comoglio F, Hansmann ML, Yakunin AF, Geisslinger G, Ströbel P, Ferreirós N, Serve H, Keppler OT, Cinatl J Jr.

Nat Med. 2017 Feb;23(2):250-255. doi: 10.1038/nm.4255. Epub 2016 Dec 19. Erratum in: Nat Med. 2017 Jun 6;23 (6):788.

PMID:
27991919
42.

Transition-Metal-like Behavior of Main Group Elements: Ligand Exchange at a Phosphinidene.

Hansmann MM, Bertrand G.

J Am Chem Soc. 2016 Dec 14;138(49):15885-15888. Epub 2016 Dec 2.

PMID:
27960331
43.

Nucleophilic T-Shaped (LXL)Au(I)-Pincer Complexes: Protonation and Alkylation.

Kleinhans G, Hansmann MM, Guisado-Barrios G, Liles DC, Bertrand G, Bezuidenhout DI.

J Am Chem Soc. 2016 Dec 14;138(49):15873-15876. Epub 2016 Dec 2.

PMID:
27960301
44.

Atypical variants of nodular lymphocyte-predominant Hodgkin lymphoma show low microvessel density and vessels of distention type.

Scheidt V, Hansmann ML, Schuhmacher B, Döring C, Hartmann S.

Hum Pathol. 2017 Feb;60:129-136. doi: 10.1016/j.humpath.2016.10.008. Epub 2016 Nov 2.

PMID:
27816718
45.

New Pathways for the Dual Gold-Catalyzed Cyclization of Diynes.

Tšupova S, Hansmann MM, Rudolph M, Rominger F, Hashmi AS.

Chemistry. 2016 Nov 2;22(45):16286-16291. doi: 10.1002/chem.201602873. Epub 2016 Sep 30.

PMID:
27689676
46.

A strong host response and lack of MYC expression are characteristic for diffuse large B cell lymphoma transformed from nodular lymphocyte predominant Hodgkin lymphoma.

Schuhmacher B, Rengstl B, Döring C, Bein J, Newrzela S, Brunnberg U, Kvasnicka HM, Vornanen M, Küppers R, Hansmann ML, Hartmann S.

Oncotarget. 2016 Nov 1;7(44):72197-72210. doi: 10.18632/oncotarget.12363.

47.

Frequent NFKBIE deletions are associated with poor outcome in primary mediastinal B-cell lymphoma.

Mansouri L, Noerenberg D, Young E, Mylonas E, Abdulla M, Frick M, Asmar F, Ljungström V, Schneider M, Yoshida K, Skaftason A, Pandzic T, Gonzalez B, Tasidou A, Waldhueter N, Rivas-Delgado A, Angelopoulou M, Ziepert M, Arends CM, Couronné L, Lenze D, Baldus CD, Bastard C, Okosun J, Fitzgibbon J, Dörken B, Drexler HG, Roos-Weil D, Schmitt CA, Munch-Petersen HD, Zenz T, Hansmann ML, Strefford JC, Enblad G, Bernard OA, Ralfkiaer E, Erlanson M, Korkolopoulou P, Hultdin M, Papadaki T, Grønbæk K, Lopez-Guillermo A, Ogawa S, Küppers R, Stamatopoulos K, Stavroyianni N, Kanellis G, Rosenwald A, Campo E, Amini RM, Ott G, Vassilakopoulos TP, Hummel M, Rosenquist R, Damm F.

Blood. 2016 Dec 8;128(23):2666-2670. Epub 2016 Sep 26.

48.

Concepts in mature T-cell lymphomas - highlights from an international joint symposium on T-cell immunology and oncology.

Herling M, Rengstl B, Scholtysik R, Hartmann S, Küppers R, Hansmann ML, Diebner HH, Roeder I, Abken H, Newrzela S, Kirberg J.

Leuk Lymphoma. 2017 Apr;58(4):788-796. doi: 10.1080/10428194.2016.1222381. Epub 2016 Sep 19.

PMID:
27643643
49.

The Propargyl Rearrangement to Functionalised Allyl-Boron and Borocation Compounds.

Wilkins LC, Lawson JR, Wieneke P, Rominger F, Hashmi AS, Hansmann MM, Melen RL.

Chemistry. 2016 Oct 4;22(41):14618-24. doi: 10.1002/chem.201602719. Epub 2016 Aug 19.

PMID:
27538742
50.

Inactivation of the putative ubiquitin-E3 ligase PDLIM2 in classical Hodgkin and anaplastic large cell lymphoma.

Wurster KD, Hummel F, Richter J, Giefing M, Hartmann S, Hansmann ML, Kreher S, Köchert K, Krappmann D, Klapper W, Hummel M, Wenzel SS, Lenz G, Janz M, Dörken B, Siebert R, Mathas S.

Leukemia. 2017 Mar;31(3):602-613. doi: 10.1038/leu.2016.238. Epub 2016 Aug 19.

Supplemental Content

Loading ...
Support Center